In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
24 authors.
Ryosuke HamashimaDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0009-0002-7589-6684 Masato TashiroDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0001-7609-7679 Yuichiro NakanoDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0009-0006-7110-5952 Tomoyuki ShirahigeDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0003-0458-3090 Hotaka NamieDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0009-0002-2561-1644 Hiromu YanoDepartment of Tumor Pathology, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0003-3985-0259 Masataka YoshidaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Satoshi KakiuchiInfection Control and Education Center, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan.ORCID 0000-0003-4957-3857 Kodai NishiDepartment of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.ORCID 0000-0002-4919-7639 Hong LiuDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.ORCID 0009-0008-3804-9535 Takahiro TakazonoDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0002-0696-5386 Takeshi TanakaInfectious Diseases Treatment and Prevention Center, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan.ORCID 0000-0003-0768-9528 Akira WatanabeDivision of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.ORCID 0000-0002-3057-2937 Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Akitsugu FurumotoInfectious Diseases Experts Training Center, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan.ORCID 0000-0001-6656-6929 Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0002-1429-5706 Scott G FillerDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.ORCID 0000-0001-7278-3700 Koichi TakayamaDepartment of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.ORCID 0000-0002-7723-8960 Koichi IzumikawaDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID 0000-0001-9969-824X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
An aspergilloma is a fungus ball that forms within a preexisting cavity, most commonly in the lungs but also in the paranasal sinuses. It represents a chronic inflammatory disorder that can persist for months and cause life-threatening hemoptysis. In this study, we hypothesized that the fungus ball is predominantly composed of non-viable hyphae and that chronic inflammation is maintained primarily by host responses to these non-viable elements rather than by ongoing fungal proliferation. To investigate this, we created a murine fungus ball model by implanting heat-killed
Indexed as
angiogenesisanimal modelaspergillomaAspergillus fumigatuschronic inflammationdead hyphaefoam cellfungus balllipid metabolism
Identifiers
PMID41874171
PMCPMC13141880
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390